日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD160(+) intraepithelial lymphocytes and CCRL2(+) macrophages drive differential repair in cardiac and liver injuries

CD160(+)上皮内淋巴细胞和CCRL2(+)巨噬细胞在心脏和肝脏损伤中发挥不同的修复作用

Sun, Kang; Dong, Jia-Xin; Mao, Xin-Tao; Li, Wen-Ping; Wang, Yu; Teng, Xiao-Mei; Liu, Dan-Dan; Yang, Bing; Zhong, Jiang-Yan; Shen, Zhenya; Li, Yi-Yuan; Jin, Jin

CCRL2 and who? An important driver in TP53-mutant myeloid leukemias

CCRL2及其作用对象?TP53突变型髓系白血病的重要驱动因素

Arnold, Olivia; Saygin, Caner

A Study on the Association of Ccrl2 Atypical Chemokine Receptor Polymorphism with the Disease Progression of Multiple Sclerosis in Turkish Patients: Insights From a Negative Study

一项关于CCRL2非典型趋化因子受体多态性与土耳其多发性硬化症患者疾病进展相关性的研究:来自一项阴性研究的启示

Özen, Nazire Pınar Acar; Horzum, Utku; Karabudak, Rana; Tuncer, Aslı

Targeting CCRL2 enhances therapeutic outcomes in a tuberculosis mouse model

靶向 CCRL2 可增强结核病小鼠模型的治疗效果

Tianyin Wang # ,Darla Quijada # ,Taha Ahmedna ,Jennie Ruelas Castillo ,Nour Sabiha Naji ,J David Peske ,Petros C Karakousis ,Suman Paul ,Theodoros Karantanos # ,Styliani Karanika #

Multiscale Computational Dissection of CCRL2-Mediated Chemerin Presentation

利用多尺度计算方法剖析CCRL2介导的趋化因子呈递

Migliorini, Arianna; Di Cristofano, Samuele; Dishnica, Klevia; Marchetto, Alessandro; Ribeiro, Rui Pedro; Laffranchi, Mattia; Cerioni, Elena; Quilli, Francesco; Bonanni, Eleonora; Giorgetti, Alejandro; Rossetti, Giulia; Sozzani, Silvano; Borsello, Tiziana; Raimondo, Domenico

CCRL2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53

CCRL2促进具有红系分化和TP53突变的髓系肿瘤中的干扰素-γ信号反应

Naji, Nour Sabiha; Pasca, Sergiu; Chatzilygeroudi, Theodora; Toledano-Sanz, Pablo; Rimando, Joseph; Hemani, Yashvi; Perkins, Brandy; Zeng, Xinghan; Talbot, Conover; Paun, Bogdan; Abdulmalik, Abdulmuez; Lossos, Chen; Boronina, Tatianna R; Sinanidis, Ilias; Tsakiroglou, Panagiotis; Fernandes, Priyanka; Esteb, Christopher; Ambinder, Alexander J; Cole, Robert N; Xian, Rena; Gojo, Ivana; Paul, Suman; Levis, Mark J; DeZern, Amy E; Luznik, Leo; Karanika, Styliani; Resar, Linda S; Jones, Richard J; Bunz, Frederick; Gondek, Lukasz; Arvanitis, Marios; Karantanos, Theodoros

A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML.

一种含有 PBD-二聚体的抗体药物偶联物,靶向 CCRL2,用于治疗高危 MDS/AML。

Endothelial CCRL2 induced by disturbed flow promotes atherosclerosis via chemerin-dependent β2 integrin activation in monocytes

紊乱血流诱导的内皮细胞CCRL2通过趋化因子依赖性β2整合素激活单核细胞促进动脉粥样硬化

Chaojun Tang ,Guona Chen ,Fan Wu ,Yiren Cao ,Fei Yang ,Tao You ,Chu Liu ,Menglu Li ,Shuhong Hu ,Lijie Ren ,Qiongyu Lu ,Wei Deng ,Ying Xu ,Guixue Wang ,Hanjoong Jo ,Yonghong Zhang ,Yi Wu ,Brian A Zabel ,Li Zhu

From cell surface to nucleus: CCRL2 regulates response to hypomethylating agents in myelodysplastic syndromes

从细胞表面到细胞核:CCRL2 调节骨髓增生异常综合征中对低甲基化药物的反应

Saygin, Caner

The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia

非典型趋化因子受体CCRL2在骨髓增生异常综合征和继发性急性髓系白血病中的作用

Theodoros Karantanos ,Patric Teodorescu ,Brandy Perkins ,Ilias Christodoulou ,Christopher Esteb ,Ravi Varadhan ,Eric Helmenstine ,Trivikram Rajkhowa ,Bogdan C Paun ,Challice Bonifant ,W Brian Dalton ,Lukasz P Gondek ,Alison R Moliterno ,Mark J Levis ,Gabriel Ghiaur ,Richard J Jones